Busulfan and Nephropathy toxic - a phase IV clinical study of FDA data
Summary:
Nephropathy toxic is reported as a side effect among people who take Busulfan (busulfan), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Cyclosporine, and have Bone marrow conditioning regimen.
The phase IV clinical study analyzes which people have Nephropathy toxic when taking Busulfan. It is created by eHealthMe based on reports of 14,527 people who have side effects when taking Busulfan from the FDA, and is updated regularly.
What is Busulfan?
Busulfan has active ingredients of busulfan. eHealthMe is studying from 14,527 Busulfan users. Check the latest studies of Busulfan.
What is Nephropathy toxic?
Nephropathy toxic (damage to kidney due to toxins) is found to be associated with 597 drugs and 739 conditions by eHealthMe. Check the latest studies of Nephropathy toxic.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14,527 people reported to have side effects when taking Busulfan.
Among them, 83 people (0.57%) have Nephropathy toxic.

Among these 83 people:
How long have people been on Busulfan when they have Nephropathy toxic? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Nephropathy toxic when taking Busulfan? *
- female: 46.15 %
- male: 53.85 %
What is the age of people who have Nephropathy toxic when taking Busulfan? *
- 0-1: 26.67 %
- 2-9: 15.56 %
- 10-19: 33.33 %
- 20-29: 8.89 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 6.67 %
- 60+: 8.89 %
What are other drugs people take besides Busulfan? *
- Cyclosporine: 20 people, 24.10%
- Cyclophosphamide: 19 people, 22.89%
- Mycophenolate Mofetil: 14 people, 16.87%
- Melphalan: 11 people, 13.25%
- Methotrexate: 11 people, 13.25%
- Ciclosporin: 10 people, 12.05%
- Ganciclovir: 9 people, 10.84%
- Methylprednisolone: 8 people, 9.64%
- Prednisone: 7 people, 8.43%
- Budesonide: 7 people, 8.43%
What are other side effects people have besides Nephropathy toxic? *
- Drug Ineffective: 19 people, 22.89%
- Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 16 people, 19.28%
- Mucosal Inflammation (infection of mucous membrane): 16 people, 19.28%
- Bk Virus Infection: 15 people, 18.07%
- Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 13 people, 15.66%
- Cytomegalovirus Chorioretinitis (infection of choroid and retina of the eye from virus): 11 people, 13.25%
- Encephalitis Cytomegalovirus (inflammation of the brain due to cytomegalovirus): 10 people, 12.05%
- Fever: 10 people, 12.05%
- Renal Impairment (severely reduced kidney function): 10 people, 12.05%
- Cytomegalovirus Infection: 9 people, 10.84%
What are the existing conditions these people have? *
- Bone Marrow Conditioning Regimen: 49 people, 59.04%
- Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 24 people, 28.92%
- Cytomegalovirus Infection: 20 people, 24.10%
- Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 14 people, 16.87%
- Cytomegalovirus Chorioretinitis (infection of choroid and retina of the eye from virus): 14 people, 16.87%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 13 people, 15.66%
- Haematopoietic Stem Cell Mobilisation: 9 people, 10.84%
- Encephalitis Cytomegalovirus (inflammation of the brain due to cytomegalovirus): 8 people, 9.64%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 8.43%
- Bk Virus Infection: 7 people, 8.43%
* Approximation only. Some reports may have incomplete information.
Do you take Busulfan and have Nephropathy toxic?
- Check whether Nephropathy toxic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Busulfan:
- Busulfan (14,527 reports)
Nephropathy toxic treatments and more:
- Nephropathy toxic (11,394 reports)
How severe was Nephropathy toxic and when was it recovered:
Expand to all the drugs that have ingredients of busulfan:
- Nephropathy toxic and drugs with ingredients of busulfan (102 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Busulfan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Nephropathy toxic:
- Nephropathy toxic (597 drugs)
Browse all the conditions that are associated with Nephropathy toxic:
- Nephropathy toxic (739 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on busulfan (the active ingredients of Busulfan) and Busulfan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zantac cause The Flu? - a second ago
- Cataplexy and Otitis - 2 seconds ago
- Drug interactions of Profen and Asa - 2 seconds ago
- Burkitt Lymphoma and Seasonal Allergy - 2 seconds ago
- Could Merrem cause Aspartate Aminotransferase Increased? - 3 seconds ago
- Could Meropenem cause Ureaplasma Infection? - 6 seconds ago
- Could Meropenem cause Deafness Neurosensory? - 8 seconds ago
- Could Hydramine cause Lip And/Or Oral Cavity Cancer? - 10 seconds ago
- Levitra vs. Viagra, side effect and effectiveness comparison - 14 seconds ago
- Broken Bone and Nausea - 22 seconds ago